Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $14.8200 (1.4%) ($14.5000 - $14.8200) on Mon. Aug. 15, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.5% (three month average) | RSI | 88 | Latest Price | $14.8200(1.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 15.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VUG(33%) XLK(33%) VT(32%) BLOK(30%) URA(30%) | Factors Impacting BCRX price | BCRX will decline at least -2.25% in a week (0% probabilities). VIXM(-16%) UUP(-14%) SMH(-9%) EDOC(-5%) VXX(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.25% (StdDev 4.5%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.61(1.44%) | 10 Day Moving Average | $13.78(7.55%) | 20 Day Moving Average | $12.54(18.18%) | To recent high | 0% | To recent low | 74.1% | Market Cap | $2.615b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |